You just read:

BioMarin Announces Exercise in Full of Underwriters' Option to Purchase Additional 0.599% Senior Subordinated Convertible Notes Due 2024

News provided by

BioMarin Pharmaceutical Inc.

Aug 23, 2017, 16:05 ET